Topics
ONE TIME EVENT
The Value of Biosimilar Trastuzumab in the Treatment of HER2 Positive Breast Cancer.
ONE TIME EVENT
Emerging Role of PI3Ka Inhibitor in HR+ HER2- aBC: #ANewHope for Breast Cancer
ONE TIME EVENT
The Role of Novel Agents in Relapsed/Refractory Mantle Cell Lymphoma
ONE TIME EVENT
The Last Frontier: Metastatic Triple Negative Breast Cancer on Immunotherapy
PSMO 20TH MIDYEAR CONVENTION
Current Evidence of CDK4/6 Inhibitors in Breast Cancer Management